Vimarsana
Biggest News Aggregation in the World

Kim Thacker News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kim Thacker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kim Thacker Today - Breaking & Trending Today

BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update - Vimarsana News

BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update

Published: August 16, 2022

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...

Source: prnewswire.com
Related Topics:
United StatesStanford SchoolJohn MullalyKim ThackerNetta Blondheim ShragaChaim LebovitsAntal Pearl LendnerJonathan KatzRalph KernSidney SpectorLisa GuitermanJames BerryDrug Administration For NurownStanford School Of MedicineCalifornia Pacific Medical CenterResearch DevelopmentPreclinical ResearchInternational Society For Extracellular VesiclesNeurology DepartmentCalifornia Institute For Regenerative MedicineBrainstorm Cell Therapeutics IncEuropean Network For The CureLifesci AdvisorsDrug AdministrationInternational Society
BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update - Vimarsana News

BrainStorm Cell Therapeutics Announces Second Quarter 2022 Financial Results and Provides a Corporate Update

Published: August 15, 2022

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...

Source: prnewswire.com
Related Topics:
United StatesStanford SchoolJohn MullalyKim ThackerNetta Blondheim ShragaChaim LebovitsAntal Pearl LendnerJonathan KatzRalph KernSidney SpectorLisa GuitermanJames BerryDrug Administration For NurownStanford School Of MedicineCalifornia Pacific Medical CenterResearch DevelopmentPreclinical ResearchInternational Society For Extracellular VesiclesNeurology DepartmentCalifornia Institute For Regenerative MedicineBrainstorm Cell Therapeutics IncEuropean Network For The CureLifesci AdvisorsDrug AdministrationInternational Society
Brainstorm Cell Therapeutics Inc.'s (BCLI) CEO Chaim Lebovits on Q1 2022 Results - Earnings Call Transcript - Vimarsana News

Brainstorm Cell Therapeutics Inc.'s (BCLI) CEO Chaim Lebovits on Q1 2022 Results - Earnings Call Transcript

Published: May 16, 2022

Brainstorm Cell Therapeutics Inc. (NASDAQ:NASDAQ:BCLI) Q1 2022 Earnings Conference Call May 16, 2022 8:00 A.M.

Source: seekingalpha.com
Related Topics:
United StatesKim ThackerMichelle LorenzNetta Blondheim ShragaChaim LebovitsTom GalassiBilly DunnDaniel WalkerAntal Pearl LendnerDavid SetbounRalph KernAaron GertlerDavid BautzStacy LindborgCompany ParticipantsBrainstorm Cell Therapeutics IncInternational Society Of Cell Gene Therapy ConferenceGe CapitalCap ResearchDrug Development SummitResearch DevelopmentTeva PharmaceuticalsAmerican Academy Of NeurologyAccess ProgramInternational Progressive Ms Alliance
BrainStorm Cell Therapeutics Announces First Quarter 2022 Financial Results and Provides a Corporate Update - Vimarsana News

BrainStorm Cell Therapeutics Announces First Quarter 2022 Financial Results and Provides a Corporate Update

Published: May 16, 2022

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, today...

Source: prnewswire.com
Related Topics:
United StatesJohn MullalySeanm HealeyKim ThackerAntal Pearl LendnerNetta Blondheim ShragaChaim LebovitsJames BerryBrainstorm Cell Therapeutics IncCalifornia Institute For Regenerative MedicineLifesci AdvisorsDrug Development SummitInternational SocietyDrug AdministrationResearch DevelopmentResearch Summit OnPrnewswire Brainstorm Cell Therapeutics IncNational Ms SocietyEuropean Medicines AgencyAmerican Academy Of NeurologyVirtual CongressChief LegalStorm Cell TherapeuticsChief ExecutiveWinthrop Family Scholar
BrainStorm Announces Presentation of NurOwn® Exosome Preclinical Data at ISCT 2022 San Francisco Meeting - Vimarsana News

BrainStorm Announces Presentation of NurOwn® Exosome Preclinical Data at ISCT 2022 San Francisco Meeting

Published: May 4, 2022

/PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (NASDAQ: BCLI), a leading developer of cellular therapies for neurodegenerative diseases, announced the...

Source: prnewswire.com
Related Topics:
United StatesSan FranciscoJohn MullalyKim ThackerRalph KernChaim LebovitsCalifornia Institute For Regenerative MedicineBrainstorm Cell Therapeutics IncLifesci AdvisorsInternational SocietyDrug AdministrationInternational Society For CellNational Ms SocietyEuropean Medicines AgencyBrainstorm Cell TherapeuticsGene TherapySenior Vice PresidentMedical AffairsClinical InnovationBrainstorm CellWednesday MayPacific TimeChief Medical OfficerChief Executive OfficerStorm Cell Therapeutics